Bioceres Crop Solutions (BIOX)
(Delayed Data from NSDQ)
$12.05 USD
-0.03 (-0.25%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $12.05 0.00 (0.00%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMBalance Sheet
Fiscal Year End for Bioceres Crop Solutions Corp falls in the month of June.
All items in Millions except Per Share data.
6/30/2023 | 6/30/2022 | 6/30/2021 | 6/30/2020 | 6/30/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 60 | 39 | 47 | 56 | 8 |
Receivables | 196 | 133 | 101 | 78 | 62 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 141 | 126 | 63 | 30 | 28 |
Other Current Assets | 0 | 0 | 0 | 0 | 0 |
Total Current Assets | 397 | 298 | 211 | 165 | 98 |
Net Property & Equipment | 68 | 50 | 48 | 42 | 44 |
Investments & Advances | 43 | 39 | 32 | 25 | 26 |
Other Non-Current Assets | 3 | 3 | 3 | 2 | 2 |
Deferred Charges | 7 | 4 | 3 | 3 | 4 |
Intangibles | 286 | 113 | 96 | 61 | 69 |
Deposits & Other Assets | 0 | 0 | 0 | 0 | 0 |
Total Assets | 818 | 518 | 395 | 298 | 242 |
Liabilities & Shareholders Equity | 6/30/2023 | 6/30/2022 | 6/30/2021 | 6/30/2020 | 6/30/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 151 | 126 | 72 | 57 | 41 |
Current Portion Long-Term Debt | 108 | 71 | 77 | 64 | 66 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 0 | 0 | 0 | 0 | 0 |
Income Taxes Payable | 1 | 8 | 7 | 2 | 0 |
Other Current Liabilities | 36 | 17 | 11 | 7 | 9 |
Total Current Liabilities | 299 | 223 | 168 | 131 | 116 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 38 | 29 | 26 | 17 | 21 |
Convertible Debt | 75 | 13 | 49 | 43 | 0 |
Long-Term Debt | 61 | 74 | 48 | 41 | 37 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 5 | 11 | 14 | 5 | 6 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 488 | 360 | 304 | 237 | 180 |
Shareholders Equity | 6/30/2023 | 6/30/2022 | 6/30/2021 | 6/30/2020 | 6/30/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 326 | 158 | 120 | 96 | 96 |
Retained Earnings | -14 | -33 | -25 | -19 | -22 |
Other Equity | 49 | 37 | 0 | -17 | -12 |
Treasury Stock | 31 | 4 | 4 | 0 | 0 |
Total Shareholder's Equity | 331 | 158 | 90 | 61 | 62 |
Total Liabilities & Shareholder's Equity | 818 | 518 | 395 | 298 | 242 |
Total Common Equity | 331 | 158 | 90 | 61 | 62 |
Shares Outstanding | 62.80 | 41.10 | 41.10 | 36.10 | 36.10 |
Book Value Per Share | 5.26 | 3.85 | 2.20 | 1.68 | 1.72 |
Fiscal Year End for Bioceres Crop Solutions Corp falls in the month of June.
All items in Millions except Per Share data.
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | -99,999 | 41 | 43 | 60 | 71 |
Receivables | NA | 226 | 213 | 196 | 197 |
Notes Receivable | NA | 0 | 0 | 0 | 0 |
Inventories | NA | 125 | 139 | 141 | 153 |
Other Current Assets | NA | 0 | 0 | 0 | 0 |
Total Current Assets | NA | 392 | 395 | 397 | 421 |
Net Property & Equipment | NA | 71 | 70 | 68 | 66 |
Investments & Advances | NA | 47 | 45 | 43 | 40 |
Other Non-Current Assets | NA | 2 | 2 | 3 | 3 |
Deferred Charges | NA | 9 | 8 | 7 | 6 |
Intangibles | NA | 285 | 285 | 286 | 297 |
Deposits & Other Assets | NA | 0 | 0 | 0 | 0 |
Total Assets | NA | 820 | 820 | 818 | 847 |
Liabilities & Shareholders Equity | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 |
---|---|---|---|---|---|
Notes Payable | NA | 0 | 0 | 0 | 0 |
Accounts Payable | NA | 164 | 159 | 151 | 150 |
Current Portion Long-Term Debt | NA | 114 | 101 | 108 | 108 |
Current Portion Capital Leases | NA | 0 | 0 | 0 | 0 |
Accrued Expenses | NA | 0 | 0 | 0 | 0 |
Income Taxes Payable | NA | 1 | 1 | 1 | 1 |
Other Current Liabilities | NA | 34 | 47 | 36 | 41 |
Total Current Liabilities | NA | 317 | 312 | 299 | 303 |
Mortgages | NA | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | NA | 45 | 37 | 38 | 47 |
Convertible Debt | NA | 78 | 77 | 75 | 74 |
Long-Term Debt | NA | 32 | 49 | 61 | 68 |
Non-Current Capital Leases | NA | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | NA | 4 | 5 | 10 | |
Minority Interest (Liabilities) | NA | 0 | 0 | 0 | 0 |
Total Liabilities | NA | 484 | 487 | 488 | 513 |
Shareholders Equity | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 |
---|---|---|---|---|---|
Preferred Stock | NA | 0 | 0 | 0 | 0 |
Common Stock (Par) | NA | 0 | 0 | 0 | 0 |
Capital Surplus | NA | 327 | 326 | 326 | 324 |
Retained Earnings | NA | -18 | -18 | -14 | -12 |
Other Equity | NA | 58 | 56 | 49 | 52 |
Treasury Stock | NA | 31 | 31 | 31 | 30 |
Total Shareholder's Equity | NA | 335 | 333 | 331 | 334 |
Total Liabilities & Shareholder's Equity | NA | 820 | 820 | 818 | 847 |
Total Common Equity | 0 | 335 | 333 | 331 | 334 |
Shares Outstanding | 62.80 | 62.80 | 62.80 | 62.80 | 63.30 |
Book Value Per Share | 0.00 | 5.34 | 5.30 | 5.26 | 5.28 |